Search Results 1011-1020 of 16952 for mindset intervention

1. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

   Subject is receiving treatment with any of the following drugs or interventions within the corresponding timeframe: CYP2C8 inhibitors (eg, gemfibrozil or ...

2. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

   ... intervention * ALT or AST > 2.0 × ULN * Total bilirubin > 2 × ULN (participants with Gilbert's syndrome can be included with total bilirubin > 2 × ULN as ...

3. A Study to Evaluate the Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes Following Lung Transplant

   The purpose of this study is to to mechanistically investigate the effect of specific inspiratory muscle training on respiratory function, exercise capacity, ...

4. Healthy Populations Sensor Intravariability Testing - Mayo Clinic

   Inclusion Criteria: Healthy individuals 18 years of age or older. Exclusion Criteria: Individuals unable to walk without a walking aid.

5. A Study to Collect Surgical Tumor Samples for Prostate Cancer-derived Tissue Graft - Mayo Clinic

   About this study. The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future ...

6. Joel Streed | Mayo Clinic News Network - Page 160 of 170

   Doctors at Mayo Clinic in Florida and Minnesota are using a new technique to stabilize glaucoma and preserve vision. Glaucoma is an eye disease that[...] By ...

7. A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis - Mayo Clinic

   * Completed study intervention in NN6019-4940 and attended the last study visit (week 64; visit 16), and no later than 12 weeks after visit 16. * Expected ...

8. Alex Chipperfield, MBBS, MRCS, FRCS (Tr & Orth) - Mayo Clinic Healthcare

   He is a high-volume arthroplasty surgeon dedicated to innovation and improved outcomes through enhanced recovery, biological interventions, technological ...

9. RESET-SLE: A Phase 1/​2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus - Mayo Clinic

   * Active infection requiring medical intervention at screening * Current symptoms of severe, progressive, or uncontrolled renal, hepatic, hematological ...

10. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 x ULN if no liver involvement or ≤ 5 x the ULN if known liver involvement; ...